+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Gene Editing Market by CRISPR, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6017517
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The gene editing market is evolving rapidly, redefining scientific and commercial boundaries across biotechnology, agriculture, and healthcare. Senior decision-makers need a comprehensive perspective to benchmark emerging trends, assess investment priorities, and anticipate regulatory changes shaping this dynamic landscape.

Market Snapshot: Gene Editing Market

The Gene Editing Market grew from USD 9.18 billion in 2024 to USD 10.89 billion in 2025. It is expected to continue growing at a CAGR of 18.10%, reaching USD 24.92 billion by 2030. This robust trajectory reflects heightened investment, rapid technology maturation, and expanding application breadth across key verticals. Sector growth is propelled by increasing adoption of advanced genomic tools, favorable regulatory momentum, and strategic partnerships among industry stakeholders. The gene editing market is also experiencing diversification in applications, setting the stage for sustained leadership in innovative therapies, agricultural improvements, and diagnostics.

Scope & Segmentation

  • Gene Editing Technologies: CRISPR systems such as Cas12, Cas13, and Cas9, alongside antisense oligonucleotides, meganucleases, RNA-guided nucleases, transcription activator-like effector nucleases (TALENs), and zinc finger nucleases (ZFNs).
  • Application Areas: Animal genetic engineering, basic research, bioenergy, cell line engineering, diagnostics, drug development, direct gene editing, plant genetic engineering, and vaccine development.
  • End Users: Academic and government research institutes, biotechnology and pharmaceutical companies, and contract research organizations (CROs).
  • Regions Analyzed: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (notably United Kingdom, Germany, France, Israel, and others), and Asia-Pacific (notably China, India, Japan, Australia, and additional markets).
  • Key Companies: Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, PerkinElmer, Agilent Technologies, Illumina, Lonza Group, GenScript Biotech, Bio-Rad Laboratories, and New England Biolabs.

Key Takeaways for Decision-Makers

  • Technology advancements are driving precision and broadening the spectrum of genomic interventions, creating new possibilities for targeted therapeutics and crop traits.
  • Evolving regulatory frameworks in major markets are streamlining clinical pathways for gene editing applications, especially in advanced therapy development.
  • Strategic collaborations among academic researchers, biotech firms, and technology suppliers are accelerating innovation cycles and reducing time-to-market for novel solutions.
  • Diversification of regional hubs is fostering innovation, with Asia-Pacific infrastructure investments and North American funding ecosystems reinforcing global market leadership.
  • Competitive differentiation is increasingly shaped by proprietary platform integration, process scale-up capabilities, and collaborative licensing or co-development agreements.
  • Stakeholders who invest in workforce development and in-house multi-disciplinary teams better manage evolving compliance standards and unlock sustainable growth potential.

Tariff Impact on Supply Chain

Recent U.S. tariff implementations have introduced cost pressures into the gene editing supply chain, notably impacting pricing for synthetic reagents and specialty enzymes. In response, manufacturers and research organizations are pursuing regional sourcing diversification and investing in tariff-free manufacturing locations. Contract research organizations have recalibrated project budgets, while several leading biotechnology enterprises are engaging policymakers to seek tariff exemptions or phased policy transitions. Such mitigation strategies are vital for maintaining supply continuity and safeguarding ongoing research initiatives within the gene editing market.

Methodology & Data Sources

This research integrates primary interviews with industry leaders and regulatory authorities, secondary analysis from peer-reviewed journals and official filings, and cross-verification through public and proprietary databases. Rigorous validation processes—such as methodological peer reviews and expert consultations—ensure data integrity and credibility of insights provided throughout the gene editing market report.

Why This Report Matters

  • Empowers senior leaders to make informed, strategy-aligned investment and market entry decisions by offering a granular, segmented view of opportunities and risks.
  • Highlights vital shifts in technology, regulation, and competitive dynamics, equipping organizations to proactively shape their product development and partnership efforts.
  • Ensures actionable intelligence for supply chain planning, regulatory compliance, and long-term talent cultivation within the gene editing market’s evolving context.

Conclusion

The gene editing market presents significant opportunities shaped by rapid advances, policy evolution, and competitive innovation. Effective strategies and partnerships will be key for sustained positioning and growth as the market continues to mature. Data-driven strategies remain critical for translating scientific breakthroughs into commercial success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gene Editing Market, by CRISPR
8.1. Introduction
8.2. Cas12
8.3. Cas13
8.4. Cas9
9. Gene Editing Market, by Technology
9.1. Introduction
9.2. Antisense oligonucleotides
9.3. CRISPR-Cas9
9.4. Meganucleases
9.5. RNA-guided nucleases
9.6. TALENs (Transcription Activator-Like Effector Nucleases)
9.7. ZFNs (Zinc Finger Nucleases)
10. Gene Editing Market, by Application
10.1. Introduction
10.2. Animal Genetic Engineering
10.3. Basic Research
10.4. Bioenergy
10.5. Cell Line Engineering
10.6. Diagnostics
10.7. Drug Development
10.8. Gene Editing
10.9. Plant Genetic Engineering
10.10. Vaccine Development
11. Gene Editing Market, by End User
11.1. Introduction
11.2. Academic & Government Research Institutes
11.3. Biotechnology & Pharmaceutical Companies
11.4. Contract Research Organizations (CROs)
12. Americas Gene Editing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gene Editing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gene Editing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Danaher Corporation
15.3.3. Merck KGaA
15.3.4. PerkinElmer, Inc.
15.3.5. Agilent Technologies, Inc.
15.3.6. Illumina, Inc.
15.3.7. Lonza Group AG
15.3.8. GenScript Biotech Corporation
15.3.9. Bio-Rad Laboratories, Inc.
15.3.10. New England Biolabs, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GENE EDITING MARKET MULTI-CURRENCY
FIGURE 2. GENE EDITING MARKET MULTI-LANGUAGE
FIGURE 3. GENE EDITING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GENE EDITING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENE EDITING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENE EDITING MARKET SIZE, BY CAS12, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENE EDITING MARKET SIZE, BY CAS13, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENE EDITING MARKET SIZE, BY CAS9, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENE EDITING MARKET SIZE, BY ANTISENSE OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR-CAS9, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENE EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENE EDITING MARKET SIZE, BY RNA-GUIDED NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENE EDITING MARKET SIZE, BY TALENS (TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES), BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENE EDITING MARKET SIZE, BY ZFNS (ZINC FINGER NUCLEASES), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENE EDITING MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENE EDITING MARKET SIZE, BY BIOENERGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENE EDITING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENE EDITING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENE EDITING MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENE EDITING MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENE EDITING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENE EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 42. CANADA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. CANADA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. MEXICO GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 46. MEXICO GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. MEXICO GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED KINGDOM GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. GERMANY GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 67. GERMANY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. GERMANY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. GERMANY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. FRANCE GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 71. FRANCE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. FRANCE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. FRANCE GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. RUSSIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 75. RUSSIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. RUSSIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. RUSSIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ITALY GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 79. ITALY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. ITALY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ITALY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. SPAIN GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 83. SPAIN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. SPAIN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SPAIN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 87. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. UNITED ARAB EMIRATES GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. SAUDI ARABIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 91. SAUDI ARABIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. SAUDI ARABIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. SAUDI ARABIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. SOUTH AFRICA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 95. SOUTH AFRICA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. SOUTH AFRICA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. SOUTH AFRICA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. DENMARK GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 99. DENMARK GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. DENMARK GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. DENMARK GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. QATAR GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 107. QATAR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. QATAR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. QATAR GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. FINLAND GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 111. FINLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. FINLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. FINLAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. SWEDEN GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 115. SWEDEN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. SWEDEN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. SWEDEN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. NIGERIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 119. NIGERIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. NIGERIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. NIGERIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. EGYPT GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 123. EGYPT GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. EGYPT GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. EGYPT GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. TURKEY GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 127. TURKEY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. TURKEY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. TURKEY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. NORWAY GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 135. NORWAY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. NORWAY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NORWAY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. POLAND GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 139. POLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. POLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. POLAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. SWITZERLAND GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 143. SWITZERLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. SWITZERLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. SWITZERLAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 151. CHINA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 152. CHINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. CHINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. CHINA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. INDIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 156. INDIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. INDIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. INDIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. JAPAN GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 160. JAPAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. JAPAN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. JAPAN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. THAILAND GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 176. THAILAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. THAILAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. THAILAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN GENE EDITING MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. GENE EDITING MARKET SHARE, BY KEY PLAYER, 2024
TABLE 200. GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gene Editing market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Lonza Group AG
  • GenScript Biotech Corporation
  • Bio-Rad Laboratories, Inc.
  • New England Biolabs, Inc.

Table Information